WCN24-1148 A NOVEL MUTATION AT C.1993C>T IN EXON 16 OF THE DAAM2 GENE CAUSING STEROID RESISTANT NEPHROTIC SYNDROME ACHIEVING LONG TERM REMISSION FOLLOWING RITUXIMAB THERAPY
Saved in:
| Main Authors: | Randula Ranawaka, Hasani Hewavitharana, Manoji Gamage, Erandima Sandamali, Vajira Dissanayake |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924011604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN25-1066 RENAL GLYCOSURIA DUE TO SLC5A2 MUTATION IN A CHILD PRESENTING WITH RECURRENT URINARY TRACT INFECTIONS AND FAILURE TO THRIVE
by: Randula Ranawaka, et al.
Published: (2025-02-01) -
Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
by: Paolo Cravedi, et al.
Published: (2024-11-01) -
DAAM is required for thin filament formation and Sarcomerogenesis during muscle development in Drosophila.
by: Imre Molnár, et al.
Published: (2014-02-01) -
Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome
by: Jialu Liu, et al.
Published: (2024-05-01) -
Advancing the Treatment of Adult Steroid-Resistant Nephrotic Syndrome: The Role of Rituximab
by: Dmytro Ivanov, et al.
Published: (2025-03-01)